Federal Trade Commission (FTC)

FTC’s Lawsuit Against Amgen Horizon Deal to Reach Court in September

May 25, 2023 - Federal Trade Commission (FTC) officials are taking Amgen and Horizon to court this September to block a prospective pharmaceutical acquisition of the two companies. The FTC announced that it planned to stop Amgen’s $27.8 billion acquisition of Horizon Therapeutics last week, citing the threat of monopolization in treatments for thyroid eye...

Read More


More Articles

Pfizer Considers Potential $40B Seagen Acquisition

by Hayden Schmidt

Pfizer Inc is reportedly in talks to buy the cancer drugmaker Seagen Inc after a potential acquisition by Merck last year fell through. In August 2022, it was reported that Merck was considering a $40...

Sun Pharmaceutical Industries Acquires Concert Pharma for $576M

by Hayden Schmidt

Last month, Sun Pharma announced that it would pay $8 per share to acquire Concert for a total of $576 million in cash. During the first three quarters of 2022, Concert recorded a net loss of nearly...

Merck & Co.‘s $40B Acquisition of Pharmaceutical Company Seagen

by Hayden Schmidt

The prospective Merck & Co. acquisition of Seattle-based biotech firm Seagen would be the largest pharmaceutical acquisition since 2020 if it is completed. Initial indications that Merck was...

Recent Articles